323 related articles for article (PubMed ID: 25916068)
21. Validated preoperative computed tomography risk estimation for postoperative hepatocellular carcinoma recurrence.
Zhang W; Lai SL; Chen J; Xie D; Wu FX; Jin GQ; Su DK
World J Gastroenterol; 2017 Sep; 23(35):6467-6473. PubMed ID: 29085196
[TBL] [Abstract][Full Text] [Related]
22. New scoring system for prediction of microvascular invasion in patients with hepatocellular carcinoma.
Shirabe K; Toshima T; Kimura K; Yamashita Y; Ikeda T; Ikegami T; Yoshizumi T; Abe K; Aishima S; Maehara Y
Liver Int; 2014 Jul; 34(6):937-41. PubMed ID: 24393295
[TBL] [Abstract][Full Text] [Related]
23. 18F-FDG PET CT as a prognostic factor in hepatocellular carcinoma.
Cho E; Jun CH; Kim BS; Son DJ; Choi WS; Choi SK
Turk J Gastroenterol; 2015 Jul; 26(4):344-50. PubMed ID: 26039005
[TBL] [Abstract][Full Text] [Related]
24. The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients.
Yang SH; Suh KS; Lee HW; Cho EH; Cho JY; Cho YB; Yi NJ; Lee KU
Liver Transpl; 2006 Nov; 12(11):1655-60. PubMed ID: 16964589
[TBL] [Abstract][Full Text] [Related]
25. Increased 18F-FDG uptake of hepatocellular carcinoma on positron emission tomography independently predicts tumor recurrence in liver transplant patients.
Kornberg A; Küpper B; Thrum K; Katenkamp K; Steenbeck J; Sappler A; Habrecht O; Gottschild D
Transplant Proc; 2009; 41(6):2561-3. PubMed ID: 19715974
[TBL] [Abstract][Full Text] [Related]
26. A survival benefit of major hepatectomy for hepatocellular carcinoma identified by preoperative [18F] fluorodeoxyglucose positron emission tomography in patients with well-preserved hepatic function.
Ahn SG; Jeon TJ; Lee SD; Kim SH; Cho HJ; Yun M; Park YN; Lee JD; Park SJ; Kim KS
Eur J Surg Oncol; 2013 Sep; 39(9):964-73. PubMed ID: 23859893
[TBL] [Abstract][Full Text] [Related]
27. Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma.
Lee JW; Paeng JC; Kang KW; Kwon HW; Suh KS; Chung JK; Lee MC; Lee DS
J Nucl Med; 2009 May; 50(5):682-7. PubMed ID: 19372474
[TBL] [Abstract][Full Text] [Related]
28. Serum Insulin-Like Growth Factor-1 (IGF-1): a Novel Prognostic Factor for Early Recurrence of Hepatocellular Carcinoma (HCC).
Yao Y; Mao W; Dong M; Yang D; Li W; Chen Y
Clin Lab; 2017 Feb; 63(2):261-270. PubMed ID: 28182337
[TBL] [Abstract][Full Text] [Related]
29. Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.
Kim YK; Lee KW; Cho SY; Han SS; Kim SH; Kim SK; Park SJ
Liver Transpl; 2010 Jun; 16(6):767-72. PubMed ID: 20517911
[TBL] [Abstract][Full Text] [Related]
30. Risk factors of microvascular invasion, portal vein tumor thrombosis and poor post-resectional survival in HBV-related hepatocellular carcinoma.
Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
Hepatogastroenterology; 2014 Sep; 61(134):1696-703. PubMed ID: 25436365
[TBL] [Abstract][Full Text] [Related]
31. Significance of preoperative fluorodeoxyglucose-positron emission tomography in prediction of tumor recurrence after liver transplantation for hepatocellular carcinoma patients: a Japanese multicenter study.
Takada Y; Kaido T; Shirabe K; Nagano H; Egawa H; Sugawara Y; Taketomi A; Takahara T; Wakabayashi G; Nakanishi C; Kawagishi N; Kenjo A; Gotoh M; Toyoki Y; Hakamada K; Ohtsuka M; Akamatsu N; Kokudo N; Takeda K; Endo I; Takamura H; Okajima H; Wada H; Kubo S; Kuramitsu K; Ku Y; Ishiyama K; Ohdan H; Ito E; Maehara Y; Honda M; Inomata Y; Furukawa H; Uemoto S; Yamaue H; Miyazaki M; Takada T;
J Hepatobiliary Pancreat Sci; 2017 Jan; 24(1):49-57. PubMed ID: 27806426
[TBL] [Abstract][Full Text] [Related]
32. (18)F-FDG-PET/CT predicts early tumor recurrence in living donor liver transplantation for hepatocellular carcinoma.
Lee SD; Kim SH; Kim YK; Kim C; Kim SK; Han SS; Park SJ
Transpl Int; 2013 Jan; 26(1):50-60. PubMed ID: 23106431
[TBL] [Abstract][Full Text] [Related]
33. Clinical Impact of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma.
Lee SD; Kim SH; Kim SK; Kim YK; Park SJ
Transplantation; 2015 Oct; 99(10):2142-9. PubMed ID: 25905981
[TBL] [Abstract][Full Text] [Related]
34. A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma.
Banerjee S; Wang DS; Kim HJ; Sirlin CB; Chan MG; Korn RL; Rutman AM; Siripongsakun S; Lu D; Imanbayev G; Kuo MD
Hepatology; 2015 Sep; 62(3):792-800. PubMed ID: 25930992
[TBL] [Abstract][Full Text] [Related]
35. Predictive value of ¹⁸F-fluorodeoxyglucose PET/CT for transarterial chemolipiodolization of hepatocellular carcinoma.
Song MJ; Bae SH; Yoo IeR; Park CH; Jang JW; Chun HJ; Choi BG; Lee HG; Choi JY; Yoon SK
World J Gastroenterol; 2012 Jul; 18(25):3215-22. PubMed ID: 22783045
[TBL] [Abstract][Full Text] [Related]
36. 18F-FDG PET in Liver Transplantation Setting of Hepatocellular Carcinoma: Predicting Histology?
Bailly M; Venel Y; Orain I; Salamé E; Ribeiro MJ
Clin Nucl Med; 2016 Mar; 41(3):e126-9. PubMed ID: 26545024
[TBL] [Abstract][Full Text] [Related]
37. Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade.
Wolfort RM; Papillion PW; Turnage RH; Lillien DL; Ramaswamy MR; Zibari GB
Int Surg; 2010; 95(1):67-75. PubMed ID: 20480845
[TBL] [Abstract][Full Text] [Related]
38. Role of ¹⁸F-FDG PET CT as an independent prognostic indicator in patients with hepatocellular carcinoma.
Pant V; Sen IB; Soin AS
Nucl Med Commun; 2013 Aug; 34(8):749-57. PubMed ID: 23689586
[TBL] [Abstract][Full Text] [Related]
39. Prediction of Posttransplantation Recurrence of Hepatocellular Carcinoma Using Metabolic and Volumetric Indices of 18F-FDG PET/CT.
Kim YI; Paeng JC; Cheon GJ; Suh KS; Lee DS; Chung JK; Kang KW
J Nucl Med; 2016 Jul; 57(7):1045-51. PubMed ID: 26985057
[TBL] [Abstract][Full Text] [Related]
40. Early diagnosis of recurrent hepatocellular carcinoma with 18F-FDG PET after radiofrequency ablation therapy.
Paudyal B; Oriuchi N; Paudyal P; Tsushima Y; Iida Y; Higuchi T; Hanaoka H; Miyakubo M; Takano A; Ishikita T; Endo K
Oncol Rep; 2007 Dec; 18(6):1469-73. PubMed ID: 17982632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]